Plain-English translation of NCT05384535 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers are testing whether a special type of MRI scan—called biparametric MRI—can help detect prostate cancer earlier in men at high risk. The study combines this MRI scan with a standard blood test (PSA) to see if together they can catch clinically significant prostate cancer before it becomes a bigger problem. If the MRI shows anything suspicious, you would have a biopsy to confirm whether cancer is present.
Current prostate cancer screening methods have limitations—they can miss some cancers or cause unnecessary worry and procedures. This study hopes that adding a specialized MRI scan to routine blood tests will improve the chances of finding important cancers while reducing false alarms in men at highest risk.
You likely qualify if…
You likely don't qualify if…
You would start with an MRI scan of your prostate, which takes about 30–45 minutes. If the scan looks normal, you'll have a PSA blood test once a year for 5 years. If the scan finds something suspicious, you'll have a follow-up biopsy procedure. Either way, you'll be checked regularly over 5 years to monitor your prostate health and catch any changes early.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
United States